Vaccination

Japan approves Novavax as 4th COVID vaccine amid new surge

Japan's health ministry on Tuesday formally approved Novavax's COVID-19 vaccine, a fourth foreign-developed tool to combat the infections as the country sees signs of a resurgence led by a subvariant of fast-spreading omicron.

Diseases, Conditions, Syndromes

Do contact-tracing apps have a future?

It may feel like a long time ago, but it's only nine months since the UK was in the grips of the "pingdemic". Back in the summer of 2021, lifting COVID restrictions saw the country's contact-tracing apps—the NHS COVID-19 ...

Diseases, Conditions, Syndromes

Not easy being green: China's 'health codes' define Covid-era life

Days after buying over-the-counter medicine from a pharmacy in Beijing, university student Yu was stunned to find her prized green health code—the essential rating needed to enter the city's shops, offices and public transport—was ...

Medications

AstraZeneca suffers diabetes drug setback for COVID

British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating COVID patients at risk of severe complications.

page 3 from 9